Moderna announced Friday that it has requested emergency use authorization for its omicron COVID-19 booster shots for children aged 6-17 years old.
Driving the news: The application for the bivalent vaccine for children ages 6 months to under 6 years old is expected to be completed later this year, the company said on Twitter.
- The Centers for Disease Control and Prevention said this week that it anticipates recommending the updated boosters for kids in early- to mid-October, pending authorization from the Food and Drug Administration.
Of note: Doses of bivalent Moderna vaccine for children aged 6-17 years are expected to come from the same vials currently used for vaccinating adults, per the CDC.
- The vaccine for children aged 6-11 years is expected to be half the volume and dosage that is currently authorized for adults, according to the CDC.
- The vaccine for those aged 12-17 years is expected be the same volume and dosage as is currently authorized for individuals aged 18 years and older.
